Peptide Research Compound (Khavinson-Type Bioregulator)
Product: Cartalax 20 mg
Active Substance: Cartalax
Strength: 20 mg/vial
Container: 2 mL vial
Manufacturer: Dragon Pharma
Out of stock
Overview
Science & Research
Safety Information
FAQ
Reviews
Dragon Pharma Peptide Product
Dragon Pharma Cartalax 20 mg Overview
Dragon Pharma Cartalax 20 mg is supplied as a lyophilized powder in a 2 mL vial and contains the synthetic tripeptide Cartalax at a labeled strength of 20 mg/vial. Product specifications, storage information, and other practical product details are provided below.
20 mg/Vial Strength
Each vial is labeled at 20 mg of Cartalax peptide.
2 mL Vial
Supplied as a lyophilized powder in a sealed 2 mL vial.
Lyophilized Form
Supplied as a freeze-dried powder for reconstitution with bacteriostatic water or suitable diluent.
Dragon Pharma
Manufactured and packaged under the Dragon Pharma product line.
Product Specifications
Product name
Cartalax 20 mg
Active substance
Cartalax
Labeled strength
20 mg/vial
Container
2 mL vial
Product form
Lyophilized powder
Manufacturer
Dragon Pharma
Related Products
Other Khavinson-type peptide bioregulators available from Dragon Pharma include Livagen 20 mg, researched for liver tissue support, and Cardiogen 20 mg, researched for cardiac tissue support. Each has a distinct amino acid sequence and tissue-specific research profile.
Science & Research
Understanding Cartalax
Cartalax is a synthetic tripeptide composed of three amino acids — alanine, glutamic acid, and aspartic acid (AED). It is classified as a Khavinson-type peptide bioregulator, a class of short peptides known for their potential to interact with chromatin and influence gene expression in a tissue-specific manner.
1
Peptide Bioregulator
Cartalax is a short tripeptide (AED) classified as a Khavinson-type peptide bioregulator, designed to influence cellular function in cartilage tissue.
2
Gene Expression Modulation
Khavinson-type peptides are researched for their potential to interact with chromatin and influence gene expression in a tissue-specific manner.
3
Cartilage Research Focus
Cartalax is specifically researched for its potential effects on chondrocyte gene expression and cartilage homeostasis.
Mechanism of Action
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) that belongs to the Khavinson class of peptide bioregulators. These short peptides are characterized by their small size and potential to interact with chromatin, influencing gene expression at the transcriptional level through epigenetic mechanisms.
Khavinson-type peptides are named after the researcher who developed them and are the subject of ongoing investigation into their potential to support tissue-specific functions. Cartalax's amino acid sequence is specifically associated with research into chondrocytes and cartilage tissue homeostasis.
Research Context
Cartalax is researched for its potential to influence chondrocyte gene expression through mechanisms involving chromatin interaction and tissue-specific gene regulation. These areas of investigation are part of broader research into peptide bioregulators and their potential applications in cartilage health.
Dragon Pharma Cartalax 20 mg is supplied as a lyophilized powder in a 2 mL vial at a labeled strength of 20 mg/vial.
Research References
Cartalax and related Khavinson-type peptides have been the subject of preclinical research investigating their properties and potential applications.
Cartalax is a research peptide with limited safety data in humans. As a peptide bioregulator that may influence gene expression and cellular function in cartilage tissue, its use requires appropriate consideration of potential physiological effects.
Cartilage Considerations
Cartalax is researched for its effects on chondrocyte function and cartilage homeostasis. Individuals with pre-existing cartilage or joint conditions should exercise caution.
Injection Site Reactions
Reconstituted peptides may cause localized reactions at the injection site. Proper aseptic technique is essential for preparation and administration.
Gene Expression Effects
As a peptide bioregulator, Cartalax may influence gene expression through chromatin interaction. The full scope of these effects is not fully characterized.
Pregnancy and Breastfeeding
Cartalax is not indicated for use during pregnancy or breastfeeding. Its effects on fetal development and infant health are not established.
Conditions That Require Medical Review
Medical advice is particularly important when there is a history of cartilage or joint conditions, autoimmune disorders, or when taking medications that may interact with connective tissue pathways.
The product should also be stored securely to prevent accidental access or use by children or other household members.
When to Seek Urgent Medical Help
Seek urgent medical attention for symptoms such as severe allergic reactions, chest pain, sudden shortness of breath, fainting, or signs of a serious adverse reaction.
Tested Sport
Cartalax is not currently listed on the WADA Prohibited List. However, the use of peptides and research compounds may be subject to specific anti-doping rules depending on the sport and governing body. Current requirements should be checked against the relevant anti-doping rules before competition.
Quick answers about Cartalax 20 mg specifications, storage, shipping, Bitcoin payment and general product information.
What is Dragon Pharma Cartalax 20 mg?
Dragon Pharma Cartalax 20 mg is a lyophilized peptide product containing Cartalax at a labeled strength of 20 mg per vial. It is supplied in a 2 mL vial as a freeze-dried powder.
What is Cartalax?
Cartalax is a synthetic tripeptide (Ala-Glu-Asp, or AED) belonging to the Khavinson class of peptide bioregulators. It is researched for its potential to interact with chromatin and influence gene expression related to chondrocytes and cartilage homeostasis.
How is Cartalax 20 mg supplied?
It is supplied as a lyophilized powder in a 2 mL vial. The product must be reconstituted with a suitable diluent such as bacteriostatic water before use in a research setting.
What is a Khavinson-type peptide bioregulator?
Khavinson-type peptide bioregulators are short synthetic peptides (typically 2-4 amino acids) that are researched for their potential to interact with chromatin and influence gene expression in a tissue-specific manner. They are named after the researcher who developed them.
Is Cartalax 20 mg FDA approved?
No. Cartalax is not FDA-approved for any therapeutic use. It is a research compound intended for laboratory and preclinical research purposes only.
How should Cartalax 20 mg be stored?
Keep the lyophilized powder in its original packaging and protect it from excessive heat, moisture and direct light. Refer to the product label for specific storage directions regarding temperature and shelf life. Once reconstituted, the solution should be used promptly or stored according to the manufacturer's directions.
Does Cartalax 20 mg require refrigeration?
Follow the storage instructions printed on the supplied product. Lyophilized peptides often require refrigeration, but specific storage conditions should be verified from the product label.
How long does Cartalax 20 mg delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy Cartalax 20 mg with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy Cartalax 20 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Is Cartalax permitted in tested sport?
Cartalax is not currently listed on the WADA Prohibited List. However, the use of peptides and research compounds may be subject to specific anti-doping rules depending on the sport and governing body. Current requirements should be checked against the relevant anti-doping rules before competition.
Where can I find more information about Cartalax?
Additional information about Cartalax and Khavinson-type peptides is available through PubMed and other research literature databases. Direct links are provided in the Science & Research section above.
